Last update : 07/22/2015 | Version : 2 | ID : 98
General | |
Identification | |
Detailed name | Longitudinal study on patients with severe Crohn's disease that did not respond to treatment and who are initiating treatment with anti-TNF alpha |
Sign or acronym | VISION |
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CNIL n°1379382 |
General Aspects | |
Medical area |
Gastroenterology et hepatology |
Keywords | psychometric validation, questionnaire, satisfaction, patients, anti-TNF alpha |
Scientific investigator(s) (Contact) | |
Name of the director | Thibout |
Surname | Emmanuel |
Phone | +33 (0)1 45 60 13 69 |
emmanuel.thibout@abbott.com | |
Collaborations | |
Funding | |
Funding status |
Private |
Details | Abbott France |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | Abbott France |
Organisation status |
Private |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Longitudinal study (except cohorts) |
Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
Database recruitment is is made on the basis of: |
Medication(s) taken |
Database recruitment is carried out as part of an interventional study |
No |
Additional information regarding sample selection. | Random selection of 30 gastroenterologists from a list of French gastroenterologists who follow and treat patients for their Crohn's disease |
Database objective | |
Main objective | Validate a new satisfaction questionnaire for patients with regards to their treatment with Anti TNF in Crohn's disease at a severe and evolving stage |
Inclusion criteria | Patients suffering from severe and evolving Crohn's disease and who have not responded to the treatments despite a complete and adapted protocol of corticotherapy and/or an immunosuppressant or intolerant to such treatments or that have medical contraindications and who move to an anti TNF treatment |
Population type | |
Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) |
Population covered |
Sick population |
Gender |
Male Woman |
Geography area |
National |
Detail of the geography area | National |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 2010 |
Date of last collection (YYYY or MM/YYYY) | 2011 |
Size of the database | |
Size of the database (number of individuals) |
< 500 individuals |
Details of the number of individuals | 300 |
Data | |
Database activity |
Current data collection |
Type of data collected |
Clinical data Declarative data |
Clinical data (detail) |
Direct physical measures |
Declarative data (detail) |
Paper self-questionnaire |
Presence of a biobank |
No |
Health parameters studied |
Others |
Other (detail) | Satisfaction questionnaire |
Procedures | |
Classifications used | CIM 10 |
Participant monitoring |
Yes |
Details on monitoring of participants | 3 months of follow-up starting from patient inclusion |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Link to the document | http://tinyurl.com/Pubmed-VISION |
Description | List of publications in Pubmed |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) | Publications |
Access to aggregated data |
Access on specific project only |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05